Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Emerg Infect Dis ; 23(11)2017 11.
Article in English | MEDLINE | ID: mdl-28930015

ABSTRACT

We collected venous and capillary serum samples from 21 Zika virus‒infected patients on multiple days after symptom onset and found RNA load was higher and median duration of virus detection significantly longer in capillary than in venous blood. These findings raise questions about the role of the capillary compartment in virus transmission dynamics.


Subject(s)
Capillaries/virology , Veins/virology , Viral Load , Zika Virus Infection/virology , Adult , Female , Humans , Male , Middle Aged , RNA, Viral/blood , Zika Virus , Zika Virus Infection/blood
2.
J Control Release ; 194: 113-21, 2014 Nov 28.
Article in English | MEDLINE | ID: mdl-25180449

ABSTRACT

There is an unmet clinical need to increase lung transplant successes, patient satisfaction and to improve mortality rates. We offer the development of a nanovector-based solution that will reduce the incidence of lung ischemic reperfusion injury (IRI) leading to graft organ failure through the successful ex vivo treatment of the lung prior to transplantation. The innovation is in the integrated application of our novel porous silicon (pSi) microparticles carrying adeno-associated virus (AAV) nanoparticles, and the use of our ex vivo lung perfusion/ventilation system for the modulation of pro-inflammatory cytokines initiated by ischemic pulmonary conditions prior to organ transplant that often lead to complications. Gene delivery of anti-inflammatory agents to combat the inflammatory cascade may be a promising approach to prevent IRI following lung transplantation. The rationale for the device is that the microparticle will deliver a large payload of virus to cells and serve to protect the AAV from immune recognition. The microparticle-nanoparticle hybrid device was tested both in vitro on cell monolayers and ex vivo using either porcine venous tissue or a pig lung transplantation model, which recapitulates pulmonary IRI that occurs clinically post-transplantation. Remarkably, loading AAV vectors into pSi microparticles increases gene delivery to otherwise non-permissive endothelial cells.


Subject(s)
Blood Vessels/metabolism , Dependovirus/immunology , Gene Transfer Techniques , Nanoparticles/chemistry , Silicon/chemistry , Animals , Blood Vessels/cytology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Gene Expression , Humans , Lung/immunology , Lung/metabolism , Lung/virology , Particle Size , Swine , Veins/immunology , Veins/virology
3.
Breast Cancer Res ; 13(4): R83, 2011 Aug 31.
Article in English | MEDLINE | ID: mdl-21884585

ABSTRACT

INTRODUCTION: Metastasis from primary tumor to the lungs is a major cause of the mortality associated with breast cancer. Both immune and inflammatory responses impact whether circulating mammary tumor cells successfully colonize the lungs leading to established metastases. Nuclear factor -kappaB (NF-κB) transcription factors regulate both immune and inflammatory responses mediated in part by the activities of macrophages. Therefore, NF-κB activity specifically within macrophages may be a critical determinant of whether circulating tumor cells successfully colonize the lungs. METHODS: To investigate NF-κB signaling within macrophages during metastasis, we developed novel inducible transgenic models which target expression of the reverse tetracycline transactivator (rtTA) to macrophages using the cfms promoter in combination with inducible transgenics that express either an activator (cIKK2) or an inhibitor (IκBα-DN). Doxycyline treatment led to activation or inhibition of NF-κB within macrophages. We used a tail vein metastasis model with mammary tumor cell lines established from MMTV-Polyoma Middle T-Antigen-derived tumors to investigate the effects of modulating NF-κB in macrophages during different temporal windows of the metastatic process. RESULTS: We found that activation of NF-κB in macrophages during seeding leads to a reduction in lung metastases. The mechanism involved expression of inflammatory cytokines and reactive oxygen species, leading to apoptosis of tumor cells and preventing seeding in the lung. Activation of NF-κB within macrophages after the seeding phase has no significant impact on establishment of metastases. CONCLUSIONS: Our results have identified a brief, defined window in which activation of NF-κB has significant anti-metastatic effects and inhibition of NF-κB results in a worse outcome.


Subject(s)
Lung Neoplasms/pathology , Lung Neoplasms/secondary , Macrophages/metabolism , Mammary Neoplasms, Experimental/pathology , NF-kappa B/metabolism , Animals , CD11b Antigen/metabolism , Chemokine CXCL9/metabolism , Female , Floxuridine/pharmacology , I-kappa B Kinase/genetics , Lung/metabolism , Lung/pathology , Lung Neoplasms/metabolism , Macrophages/drug effects , Macrophages/pathology , Mice , Mice, Transgenic , NF-kappa B/antagonists & inhibitors , Phenotype , Polyomavirus/pathogenicity , Promoter Regions, Genetic , Reactive Oxygen Species , Receptors, Colony-Stimulating Factor/genetics , Signal Transduction , Veins/virology
4.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 30(2): 156-60, 2008 Apr.
Article in Chinese | MEDLINE | ID: mdl-18505116

ABSTRACT

OBJECTIVE: To investigate the biological and clinical features of Chinese rhesus monkeys after intravenous (IV) and intrarectal (IR) challenge with SIVmac239 in rhesus monkeys of Chinese origin, and compare the differences between the routes of infection. METHODS: Rhesus monkeys of Chinese origin were inoculated with SIVmac239 either by IV (n = 19) or IR (n = 6) routes. Simian immunodeficiency virus (SIV)-specific antibody titer, CD4 + T cell counting, plasma SIV load, lymph node pathology, and clinical manifestations were compared between these two groups 232 or 168 days after challenging. RESULTS: All SIVmac239-inoculated animals became seropositive for SIV-specific antibodies. SIV-specific IgM was detected in IV groups as from day 10 but was not detected in IR for all the time points. Although SIV-specific IgG was detected as from day 30 in both groups, the IgG titers were ten-fold higher in IV group than in IR group after day 168. CD4 + T-cell counting decreased progressively in IV group but remained stable in IR group over time. Plasma SIV RNA loads peaked in all animals between day 10 and day 14 (10(7) copies/ml), then declined to "setpoint" (10(3) - 10(6) copies/ml) about 2 months later. Most inoculated animals manifested lymphadenopathy. Two animals in IV group and one in IR group died of simian AIDS between day 150 and day 210, as evidenced by the autopsies showing the depletion of lymph tissues, Pneumocystis carinii pneumonia and other opportunity infections. Conclusion IV or IR inoculation of SIVmac239 in Chinese rhesus monkeys will result in chronic SIV infection with a similar clinical feature of natural HIV infection, which provides an excellent experimental animal model for AIDS.


Subject(s)
Macaca mulatta/virology , Rectum/virology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/pathogenicity , Veins/virology , Animals , CD4-Positive T-Lymphocytes/metabolism , China , Disease Models, Animal , Female , Male , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/immunology
5.
Ann Vasc Surg ; 15(3): 367-73, 2001 May.
Article in English | MEDLINE | ID: mdl-11414089

ABSTRACT

This study examined the efficiency of adenoviral-mediated gene transfer in experimental vein grafts and cultured human saphenous vein under physiologic conditions using clinically relevant exposure times, pressures, and viral concentrations. The external jugular veins of 25 male New Zealand White rabbits were exposed to 0.5 mL of replication-deficient adenovirus vectors encoding beta-galactosidase (AdlacZ), control adenovirus (AdBg/II), or vehicle at pressures ranging from 0 to 120 mmHg for 10 min. Veins were excised and grafted into the carotid circulation. After 5 days, the vessels were reexposed, excised, and stained with X-gal chromagen for beta-galactosidase (beta-gal) activity. Gene transfer was also performed in 13 segments of human saphenous vein discarded at the time of bypass grafting. The veins were cultured for 0-21 days and assayed for beta-gal activity as above. Rabbit vein grafts exposed to high-pressure AdlacZ transfection showed significant transgene expression in 100% of grafts (39 +/- 2% positive cells/hpf) while only 60% of those transfected at low pressure expressed beta-gal (9 +/- 3% positive cells/hpf). All human veins exposed to AdlacZ expressed beta-gal to a variable degree (range 10-50% positive cells/hpf). No control grafts or veins expressed the transgene. Efficient adenoviral-mediated gene transfer in experimental vein grafts and human saphenous vein segments can be achieved using clinically feasible parameters of exposure time, pressure, and viral concentration.


Subject(s)
Gene Transfer Techniques , Veins/transplantation , Adenoviridae/genetics , Animals , Feasibility Studies , Humans , Male , Pressure , Rabbits , Time Factors , Veins/virology
6.
J Clin Virol ; 16(1): 17-24, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10680737

ABSTRACT

BACKGROUND: The biological properties of some herpesviruses such as the ability of latent persistency in the host cells and the presence of viral DNA in atherosclerotic lesions, suggest the possible role of herpesviruses in the development of atherosclerosis. Although many authors proved the presence of viral DNA in arterial wall tissue, the role of herpesviruses in the origin and progress of atherogenesis still remains unclear. OBJECTIVES: The aim of this study was to confirm the presence of viral DNA in arterial wall and to associate the presence of these viruses with the development of atherosclerosis in patients with ischemic heart disease (IHD). STUDY DESIGN: A possible role of HCMV, EBV and HHV6 in the development of atherosclerosis was tested in 244 IHD patients and 87 coronarographically negative controls. The presence of viral DNA in aortic and venous walls, as well as in a peripheral blood samples was tested by the use of polymerase chain reaction (PCR) accompanied by, immunological tests for anti-virus antibodies IgM and IgG types for all experimental groups. RESULTS: The genomic DNA of HCMV was found in 76 and 59%, DNA of EBV in 59 and 50%, and DNA of HHV6 in 0.08 and 0.0%, of arterial walls of IHD patients and non-ischemic control group, respectively. No viral DNA was found in venous samples. Significant association (P < 0.01) has been proved between CMV infection and IHD. CONCLUSIONS: Our results suggest that HCMV and EBV can be found in the arterial wall, so that the arterial wall could be a potential site of persistency of those viruses. We also proved a significant association between the presence of HCMV DNA in aortic walls and atherosclerosis. Despite of the high genetic and biological similarity between CMV and HHV6 no substantial role of HHV6 in atherosclerosis has been proved.


Subject(s)
Coronary Artery Disease/virology , Cytomegalovirus Infections/complications , Cytomegalovirus/isolation & purification , Myocardial Ischemia/virology , Aorta/virology , Cell Line , Coronary Vessels/virology , Cytomegalovirus Infections/virology , DNA, Viral/analysis , DNA, Viral/isolation & purification , Epstein-Barr Virus Infections/virology , Female , Herpesviridae Infections/virology , Herpesvirus 4, Human/isolation & purification , Herpesvirus 6, Human/isolation & purification , Humans , Leukocytes, Mononuclear/virology , Male , Middle Aged , Polymerase Chain Reaction , Veins/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...